A wide conference hall with soft natural light, neutral beige and gray tones, rows of seating, and a calm professional atmosphere

Advancing integrated care for non-communicable diseases across APEC economies

View Agenda

Bringing insulin and essential medicines closer to communities

Reliable access to insulin and other essential non-communicable disease medicines depends on more than a prescription. People need practical support with storage, transport, dosing, monitoring, refills and side effects. Community-based delivery brings these services into neighbourhoods and homes, helping people manage diabetes, cardiovascular disease and obesity-related complications with less disruption to daily life. Learn more about Per Iadr2020.com.

This approach was central to the 2023 APEC Conference on Promoting Community-based Non-Communicable Diseases Integrated Care Model. The event examined how health systems can connect prevention, primary care, medicine supply and local support, particularly for ageing populations. Its programme, speaker contributions and downloadable materials provide useful context for health professionals, community organisations and policy leaders across Australia.

Why local medicine delivery matters

Insulin treatment is highly effective when people can obtain it consistently and use it safely. Interruptions can occur when a patient cannot travel to a clinic, afford transport, arrange a repeat prescription or keep medicine at the right temperature. Older people may also be managing several conditions at once, making a standard pharmacy transaction insufficient for their needs.

Community-based delivery can include home visits, outreach clinics, pharmacist-led education, nurse follow-up and medicine collection points. These services help identify practical barriers before they become emergencies. A community nurse might notice that a person is rationing insulin, while a pharmacist may identify confusion between long-acting and rapid-acting products.

Australia’s geography makes this especially important. A person in a remote community in the Northern Territory or Western Australia may face long distances, limited transport and irregular medicine deliveries. Seasonal conditions can affect roads, while workforce turnover can make continuity of care difficult. Local Aboriginal Community Controlled Health Services are often well placed to provide culturally safe support because they understand community priorities and existing relationships.

Delivery models should be designed around people’s routines rather than asking every person to fit a centralised system. For some, that may mean a pharmacy service near a train station in suburban Melbourne. For others, it may involve a visiting health worker in regional Queensland or coordinated supply through a remote clinic.

Building a safe supply pathway

A community medicine programme needs a dependable supply chain from prescribing to administration. Insulin must be stored, transported and monitored appropriately, with clear procedures for refrigeration, temperature excursions and power outages. Staff and volunteers need to know when a product should not be used and whom to contact if a cold-chain problem occurs.

Essential NCD medicines can include glucose-lowering treatments, blood pressure tablets, statins, anticoagulants and medicines for heart failure. A single delivery may involve several products with different schedules. Packaging should be legible, instructions should use plain English, and translated or interpreted support should be available where needed.

Australia’s Pharmaceutical Benefits Scheme helps subsidise many medicines, yet the cost of prescriptions can still influence whether people collect them. Co-payments, dispensing fees and the distance to a participating pharmacy can create pressure, particularly for pensioners and people living on fixed incomes. Coordinated repeat dispensing, dose administration aids and reminder systems may reduce missed collections, but they must be matched to the individual’s preferences and capacity.

Medication reviews are another important safeguard. Older adults may receive prescriptions from a general practitioner, hospital specialist and visiting clinic, increasing the risk of duplication or interactions. Practical guidance on medication reviews can help community teams examine the full medicine list, confirm what is actually being taken and simplify treatment where clinically appropriate.

Connecting clinical care with everyday support

Medicine supply works best when paired with education and monitoring. A person starting insulin may need help understanding injection technique, timing, blood glucose results, hypoglycaemia and sick-day plans. Family members or carers may need training as well, especially when an older person has reduced vision, memory concerns or limited hand strength.

Community pharmacies can offer repeat prescription reminders, blood pressure checks and referrals to a GP or diabetes educator. Practice nurses can follow up after a hospital discharge, while Aboriginal health workers can help connect clinical advice with cultural and family contexts. These roles should complement, rather than replace, the prescribing and diagnostic responsibilities of qualified clinicians.

Technology can extend reach across Australia without making digital access a requirement. Telehealth appointments, electronic prescriptions and secure messaging can support people in regional areas, but services should retain telephone and face-to-face options. Some older Australians are uncomfortable with apps, and internet connectivity can be unreliable in remote locations. A printed care plan, a phone call and a trusted local contact may be more useful than a complex online portal.

The Australian “MyMedicare” model and broader primary-care reforms also highlight the value of an ongoing relationship with a regular practice. Community delivery should feed information back to that care team, with consent and appropriate privacy protections. Shared records can show whether medicines were collected, whether doses changed and whether symptoms require escalation.

Supporting volunteers and community workers

Volunteers can help with appointment reminders, transport coordination, social connection and practical household support, but they should not be expected to make clinical decisions. Clear role descriptions protect both the volunteer and the person receiving care. A volunteer can report that a person has missed deliveries or appears unwell; a nurse or pharmacist must then assess the situation.

Recruitment is more effective when it uses existing community networks. Local councils, multicultural associations, sporting clubs, faith organisations, neighbourhood houses and seniors’ groups may know people who are trusted and dependable. In regional towns, the local pharmacist, community centre or Aboriginal health service may be the natural hub for coordination.

Training should cover privacy, consent, infection prevention, respectful communication, recognising urgent symptoms and the limits of the volunteer role. Volunteers also need supervision, debriefing and a simple escalation pathway. Guidance on mobilising volunteers can help organisations create a structured home-based support programme rather than relying on informal goodwill.

Language and culture matter. Australia’s population includes people from many migrant communities, and a family may have different understandings of insulin, diet or chronic disease based on previous health systems. Bilingual workers and professional interpreters can improve safety. For Aboriginal and Torres Strait Islander communities, service design should be led with community input and should recognise the importance of connection to Country, family and culturally safe care.

Workforce planning also needs to account for rural and remote realities. A visiting clinician may only be present on certain days, so local staff need protocols for urgent advice and medicine continuity between visits. Partnerships with regional hospitals, aeromedical services, pharmacies and primary health networks can reduce gaps when a delivery route or staff member is unavailable.

Measuring access, safety and impact

A strong community delivery service should measure outcomes that matter to patients and health systems. Useful indicators include missed medicine collections, insulin interruptions, hypoglycaemic events, avoidable hospital presentations, blood pressure control and follow-up after discharge. Patient-reported measures can show whether people feel confident using their medicines and whether the service respects their preferences.

Data should be interpreted carefully. A rise in referrals may mean that screening has improved rather than that health has deteriorated. Low collection rates could reflect poor access, confusing records or a medicine that caused side effects. Community members should be involved in reviewing results so that numerical targets do not obscure lived experience.

Equity measures are essential. Services should examine access by age, location, disability, language, socioeconomic circumstances and Aboriginal and Torres Strait Islander identity. A programme that performs well in inner Sydney may not suit a farming district in Victoria or a remote community in the Kimberley. Funding arrangements need to recognise travel, outreach time, cold-chain equipment, interpretation and coordination.

The APEC conference model is valuable because it brings together public health, primary care, community organisations and policy voices. Its programme materials can support discussion about integrated chronic disease care, while its hybrid format demonstrates how professional learning can reach participants beyond the host venue. Australian organisations can adapt those ideas to local primary health networks, state services and community-controlled providers.

Sustainability depends on making community delivery part of routine care rather than a short-term project. Payment models should cover coordination as well as the physical medicine supply. Staff need time to communicate across services, and patients should not have to repeat their history every time a different provider becomes involved. Good systems make the safe option the easy option.

Community-based delivery for insulin and essential NCD medicines can bring treatment closer to where people live, work and age. In Australia, that means combining the strengths of GPs, pharmacists, nurses, Aboriginal health services, local organisations and families. It also means treating access, cultural safety and continuity as clinical priorities.

Health leaders, practitioners and community organisations can use the conference resources to compare models, strengthen local partnerships and plan practical pathways for diabetes and cardiovascular care. Those interested in the event’s materials and participation information can review the conference registration page, then apply the lessons to services in metropolitan, regional and remote communities.